Ilham Putra, Xiang Shen, Khandaker N Anwar, Behnam Rabiee, Ravand Samaeekia, Enmar Almazyad, Pushpanjali Giri, Sayena Jabbehdari, Mohammed R Hayat, Abdelrahman M Elhusseiny, Mahmood Ghassemi, Nadim Mahmud, Deepak P Edward, Charlotte E Joslin, Mark I Rosenblatt, Reza Dana, Medi Eslani, Peiman Hematti, Ali R Djalilian
Purpose: Mesenchymal stromal cells (MSCs) have been shown to enhance tissue repair as a cell-based therapy. In preparation for a phase I clinical study, we evaluated the safety, dosing, and efficacy of bone marrow-derived MSCs after subconjunctival injection in preclinical animal models of mice, rats, and rabbits. Methods: Human bone marrow-derived MSCs were expanded to passage 4 and cryopreserved. Viability of MSCs after thawing and injection through small-gauge needles was evaluated by vital dye staining...
August 12, 2021: Translational Vision Science & Technology